Genmab A (GMAB) Profit After Tax (2018 - 2026)

Genmab A's Profit After Tax history runs 6 years deep, the most recent figure standing at $53.0 million for Q1 2026.

• Quarterly Profit After Tax fell 72.82% year-over-year to $53.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 31.48% YoY) and the FY2025 annual result came in at $963.0 million, down 15.0% from the prior year.
• Profit After Tax was $53.0 million for Q1 2026 at Genmab A, down from $932.0 million in the prior quarter.
• Across five years, Profit After Tax topped out at $1.3 billion in Q4 2024 and bottomed at $53.0 million in Q1 2026.
• A 3-year average of $525.6 million and a median of $463.0 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2025 — Profit After Tax soared 60.41% — and 2026, when it slumped 72.82%.
• Genmab A's Profit After Tax stood at $1.3 billion in 2024, then dropped by 29.71% to $932.0 million in 2025, then plunged by 94.31% to $53.0 million in 2026.
• Business Quant data shows GMAB's Profit After Tax at $53.0 million in Q1 2026, $932.0 million in Q3 2025, and $531.0 million in Q2 2025.